Ace Therapeutics has announced the introduction of its comprehensive platform of preclinical genetic kidney disease models, aimed at accurately replicating human hereditary renal pathology. This initiative is designed to bolster…
Lixte Biotech Holdings (NASDAQ: LIXT) is making significant strides in the realm of precision oncology through the development of LB-100, a first-in-class therapy aimed at enhancing the effectiveness of established…
As of 1st July 2018, Kiran Mazumdar Shaw, who is the Chairperson and Managing Director of India's largest biotechnology company, has been appointed to serve a five-year term on the…
In a recent discussion, ADC Therapeutics provided insights into the ongoing developments surrounding its flagship product, ZYNLONTA. The conversation featured Ameet Mallik, the CEO of ADC Therapeutics, who elaborated on…
MeiraGTx Holdings plc at RBC Capital Markets Virtual Ophthalmology Conference Good morning, everyone. This is Lisa Walter, a Biotech Analyst from RBC Capital Markets. Thank you for attending the RBC's…
The biologic hernia repair mesh market is on track for significant growth in the forthcoming years, fuelled by technological advancements and shifting clinical preferences. This report provides an in-depth analysis…
Dear voters of Wilmington, It is with great enthusiasm that I encourage you to support the re-election of Jennifer Bryson and Michael Mercaldi to our school committee. Over the past…
March 27, 2026 – NU Advisory Partners has announced the addition of Caitlin Maloof, Jessica Johnson, and Alan Mait as partners, further enhancing the firm's capabilities across key sectors and…
Clockwork Bio has been established as a pioneering AI-native biotechnology company dedicated to advancing early-stage oncology drug discovery. The firm is developing a platform that focuses on modelling and controlling…
As the open enrollment period for Medicare Advantage (MA) approaches, individuals currently enrolled in private managed-care plans have the opportunity to either switch to a new plan or revert to…
